VEGFA and myeloid sarcoma: The multitasking vascular and neuroprotective effects of VEGF show promise for therapeutic use in neurodegenerative disorders such as ALS, PD, AD and, eventually, progressive MS [227–229], when its harmful vascular side effects can be restricted.